Find PharmaFlow Article for Lutetium Chloride Lu-177

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Lutetium (177lu) chloride, 16434-14-3, Lutetium chloride (177lucl3), 1u477369sn, Endolucinbeta, Lumark
Molecular Formula
Cl3Lu
Molecular Weight
283.30  g/mol
InChI Key
AEDROEGYZIARPU-SUNKFXMWSA-K
FDA UNII
1U477369SN

Lutetium Chloride Lu-177
1 2D Structure

Lutetium Chloride Lu-177

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
lutetium-177(3+);trichloride
2.1.2 InChI
InChI=1S/3ClH.Lu/h3*1H;/q;;;+3/p-3/i;;;1+2
2.1.3 InChI Key
AEDROEGYZIARPU-SUNKFXMWSA-K
2.1.4 Canonical SMILES
[Cl-].[Cl-].[Cl-].[Lu+3]
2.1.5 Isomeric SMILES
[Cl-].[Cl-].[Cl-].[177Lu+3]
2.2 Other Identifiers
2.2.1 UNII
1U477369SN
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Lutetium (177lu) Chloride

2. 16434-14-3

3. Lutetium Chloride (177lucl3)

4. 1u477369sn

5. Endolucinbeta

6. Lumark

7. Unii-1u477369sn

8. Endolucinbeta (tn)

9. Lutetium (177 Lu) Chloride

10. Lutetium-177 Chloride

11. Dtxsid20167745

12. Lutetium-177 Trichloride

13. Lutetium (177lu) Chloride [who-dd]

14. D10828

15. Q27252884

2.4 Create Date
2013-07-08
3 Chemical and Physical Properties
Molecular Weight 283.30 g/mol
Molecular Formula Cl3Lu
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass281.85032 g/mol
Monoisotopic Mass281.85032 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count4
Formal Charge0
Complexity0
Isotope Atom Count1
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Drug and Medication Information
4.1 Drug Indication

EndolucinBeta is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with Lutetium (177Lu) chloride.


Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.


Radiolabelling agent


ilLuzyce is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.


5 Pharmacology and Biochemistry
5.1 ATC Code

V10X


V10


V10X


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty